ENDEFR
Home › Sweden › Bobtail Nordic Pharma AB

Bobtail Nordic Pharma AB

Aktiebolag (AB) · Täby, Sweden · LEI 549300M4S1D310I32C41
LEI active

Summary

Bobtail Nordic Pharma AB is registered in Sweden and entered in the “Companies Register (Bolagsverket)” under number 556905-4116. Its legal form is Aktiebolag (AB) – limited company (Sweden). According to GLEIF, its ultimate parent is Odrärer Invest Aktiebolag (Sweden), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in Sweden. The LEI was first issued on 30 Jan 2021 and the record was last updated on 8 Dec 2025; the next renewal is due by 3 Feb 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formAktiebolag (AB)
limited company (Sweden)
RegisterCompanies Register (Bolagsverket) · Register website
Registration number556905-4116
Registration authoritySwedish Companies Registration Office
JurisdictionSweden
Registered addressPilfinksvägen 19, 183 51 Täby, Sweden
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)1 Oct 2012
LEI549300M4S1D310I32C41
LEI statusactive
LEI first issued30 Jan 2021
LEI record last updated8 Dec 2025
Next LEI renewal3 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

Odrärer Invest Aktiebolag Sweden ultimate parent
Bobtail Nordic Pharma AB this entity

Relationship to the parent

Direct parentUltimate parent
ParentOdrärer Invest AktiebolagOdrärer Invest Aktiebolag
Accounting period31 Dec 2023 to 30 Dec 202431 Dec 2023 to 30 Dec 2024
Evidencesupporting documentssupporting documents
Corroborationpartly corroboratedpartly corroborated
Relationship start1 Feb 20231 Feb 2023
Recorded at GLEIF since1 Feb 20231 Feb 2023
Last updated8 Dec 20258 Dec 2025
Record statuscurrentcurrent